Adenovirus infections in immuncompromised patients;Adenovírus-fertozések immunszuppresszált betegekben

Orvosi Hetilap

Volumn 153, Issue 48, 2012, Pages 1896-1904

  Stercz, Balázs ^a   Nagy, Károly ^a   Ongrádi, József ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

adenovirus serotypes; antiviral treatment; hematopoietic stem cell and organ transplantation; molecular diagnostics; opportunistic infections

Indexed keywords

CIDOFOVIR; GANCICLOVIR; MICRORNA; RIBAVIRIN; VIDARABINE; VIRUS DNA;

ADENOVIRUS INFECTION; AIDS PATIENT; ARTICLE; CYSTITIS; DISEASES; ENTERITIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN ADENOVIRUS; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; LYMPHOMA; ORGAN TRANSPLANTATION; SEROLOGY; SEROTYPE; SEVERE COMBINED IMMUNODEFICIENCY; SYSTEMIC LUPUS ERYTHEMATOSUS; TUMOR GROWTH; URINARY TRACT INFECTION; VIRUS HEPATITIS; VIRUS LATENCY; VIRUS PNEUMONIA; VIRUS REACTIVATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADENOVIRUS INFECTIONS, HUMAN; ANTIVIRAL AGENTS; GRAFT REJECTION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEOPLASMS; ORGAN TRANSPLANTATION;

EID: 84870262467     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2012.29496     Document Type: Article

References (75)

1. Liu, E. B., Ferreyra, L., Fischer, S. L., et al.: Genetic analysis of a novel human adenovirus with a serologically unique hexon and a recombinant fi ber gene. PLoS One, 2011, 6, e24491.
2. Kojaoghlanian, T., Flomenberg, P., Horwitz, M. S.: The impact of adenovirus infection on the immunocompromised host. Rev. Med. Virol., 2003, 13, 155-171. (Pubitemid 36566085)
3. Gregory, S. M., Nazir, S. A., Metcalf, J. P.: Implications of the innate immune response to adenovirus and adenoviral vectors. Future Virol., 2011, 6, 357-374.
4. Leen, A. M., Rooney, C. M.: Adenovirus as an emergin g pathogen in immunocompromised patients. Br. J. Haematol., 2005, 128, 135-144.
5. Zhao, H., Dahlö, M., Isaksson, A., et al.: The transcriptome of the adenovirus infected cell. Virology, 20 12, 424, 115-128.
6. Garnett, C. T., Talekar, G., Mahr, J. A., et al.: Latent species C adenoviruses in human tonsil tissues. J. Virol., 2009, 83, 2417-2428.
7. Ongrádi, J., Telekes, A., Farkas, J., et al.: The effect of prosta-glandins on the replication of adenovirus wild types and temperature-sensitive mutants. Acta Microbiol. Immunol. Hung., 1994, 41, 173-188.
8. Ongrádi, J., Kulcsár, G., Dán, P., et al.: Activation of adeno-virus type 5 latent infe ctions of tissue culture. Intervirology, 1980, 14, 310-315. (Pubitemid 11111344)
9. Heim, A.: Advances in the management of disseminated ade-novirus d isease in stem cell transplant recipients: impact of adenovirus load (DNAemia) testing. Expert Rev. Anti Infect. Ther., 2011, 9, 943-945.
10. Raper, S. E., Chirmule, N., Lee, F. S., et al.: Fatal systemic infl am-matory response syndrome in a ornithine transcarbamylase defi cient patient following adenoviral gene transfer. Mol. Genet. Metab., 2003, 80, 148-158. (Pubitemid 37272241)
11. Fischer, S. A.: Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV. Transplantation, 2008, 86, 1327-1339.
12. Ongrádi, J.: Identifi cation of a feline adenovirus isolate that replicates in monkey and human cells in vitro. Am. J. Vet. Res., 1999, 60, 1463.
13. Phan, T. G., Shimizu, H., Nishimura, S., et al.: Human adeno-virus type 1 related to feline adenovirus: evidence of interspecies transmission. Clin. Lab., 2006, 52, 515-518. (Pubitemid 44649682)
14. Pham, T. T., Burchette, J. L. Jr., Hale, L. P.: Fatal disseminated adenovirus infe ctions in immunocompromised patients. Am. J. Clin. Pathol., 2003, 120, 575-583. (Pubitemid 37186052)
15. Hierholzer, J. C.: Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev., 1992, 5, 262-274.
16. Ongrádi, J., Sallay, K., Kulcsár, G.: The decreased antibacterial activity of oral polymorphonuclear leukocytes coincides with the occurrence of virus-carrying oral lymphocytes and epithelial cells. Folia Microbiol. (Praha), 1987, 32, 438-447.
17. Ongrádi, J., Farkas, J., Kulcsár, G., et al.: Suppressed phagocytosis but promoted bacterial growth upon the effect of virus free supernatants of infected lymphocytes. Acta Microbiol. Immunol. Hung., 1994, 41, 51-72.
18. Echavarria, M.: Adenoviruses in immunocompromised hosts. Clin. Microbiol. Rev., 2008, 21, 704-715.
19. Crooks, B. N., Taylor, C. E., Turner, A. J., et al.: Respiratory viral infections in primary immune defi ciencies: signifi cance and relevance to clinical outcome in a single BMT unit. Bone Marrow Transplant., 2000, 26, 1097-1102.
20. Tuvia, J., Weisselberg, B., Shif, I., et al.: Aplastic anaemia complicating adenovirus infection in DiGeorge syndrome. Eur. J. Pediatr., 1988, 147, 643-644.
21. Siegal, F. P., Dikman, S. H., Arayata, R. B., et al.: Fatal disseminated adenovirus 11 pneumonia in an agammaglobulinemic patient. Am. J. Med., 1981, 71, 1062-1067. (Pubitemid 12191991)
22. Winkels tein, J. A., Marino, M. C., Lederman, H. M., et al.: X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore), 2006, 85, 193-202. (Pubitemid 44107177)
23. Van den Veyver, I. B., Ni, J., Bowles, N., et al.: Det ection of in-trauterine viral infection using the polymerase chain reaction. Mol. Genet. Metab., 1998, 63, 85-95. (Pubitemid 28453325)
24. Flomenberg, P., Babbitt, J., Drobyski, W. R., et al.: Increasing incidence of adenovirus disease in bone marrow transplant recipients. J. Infect. Dis., 1994, 169, 775-781. (Pubitemid 24102109)
25. Leruez-Ville, M., Chardin-Ouachée, M., Neven, B., et al.: Description of an adenovirus A31 outbreak in a paediatric haematology unit. Bone Marrow Transplant., 2006, 38, 23-28. (Pubitemid 43923085)
26. Kroes, A. C., de Klerk, E. P., Lankester, A. C., et al.: Sequential emergence of multiple adenovirus serotypes after pediatric stem cell transplantation. J. Clin. Virol., 2007, 38, 341-347. (Pubitemid 46413997)
27. Lion, T., Baumgartinger, R., Watzinger, F., et al.: Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood, 2003, 102, 1114-1120. (Pubitemid 36917814)
28. Schilham, M. W., Claas, E. C., van Zaane, W., et al.: High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin. Infect. Dis., 2002, 35, 526-532.
29. Ison, M. G., Green, M.: Adenovirus in solid organ transplant recipients. Am. J. Transplant., 2009, 9 (Suppl. 4), S161-S165.
30. Varma, M. C., Kushner, Y. B., Ko, D. S., et al.: Early onset adeno-virus infection after simultaneous kidney-pancreas transplant. Am. J. Transplant., 2011, 11, 623-627.
31. Shirali, G. S., Ni, J., Chinnock, R. E., et al.: Association of viral genome with graft loss in children after cardiac transplantation. N. Engl. J. Med., 2001, 344, 1498-1503. (Pubitemid 32429208)
32. Avery, R. K.: Viral triggers of cardiac-allograft dysfunction. N. Engl. J. Med., 2001, 344, 1545-1547. (Pubitemid 32429216)
33. Varki, N. M., Bhuta, S., Drake, T., et al.: Adenovirus hepatitis in two successive liver transplants in a child. Arch. Pathol. Lab. Med., 1990, 114, 106-109. (Pubitemid 20103521)
34. Lecatsas, G., van Wyk, J. A.: DNA viruses in urine after renal transplantation. S. Afr. Med. J., 1978, 53, 787-788. (Pubitemid 8358998)
35. Sujeet, K., Vasudev, B., Desai, P., et al.: Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient. Transpl. Infect. Dis., 2011, 13, 174-177.
36. Harnett, G. B., Bucens, M. R., Clay, S. J., et al.: Acute haemor-rhagic cystitis caused by adenovirus type 11 in a recipient of a transplanted kidney. Med. J. Aust., 1982, 1, 565-567. (Pubitemid 12018014)
37. Watcharananan, S. P., Avery, R., Ingsathit, A., et al.: Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery. Am. J. Transplant., 2011, 11, 1308-1314.
38. Ardehali, H., Volmar, K., Roberts, C., et al.: Fatal disseminated adenoviral infection in a renal transplant patient. Transplantation, 2001, 71, 998-999. (Pubitemid 32417366)
39. Hofland, C. A., Eron, L. J., Washecka, R. M.: Hemorrhagic ade-novirus cystitis after renal transplantation. Transplant. Proc., 2004, 36, 3025-3027. (Pubitemid 41126732)
40. Matar, L. D., McAdams, H. P., Palmer, S. M., et al.: Respiratory viral infections in lung transplant recipients: radiologic fi ndings with clinical correlation. Radiology, 1999, 213, 735-742.
41. Doan, M. L., Mallory, G. B., Kaplan, S. L., et al.: Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J. Heart Lung Transplant., 2007, 26, 883-889. (Pubitemid 47376820)
42. Ziring, D., Tran, R., Edelstein, S., et al.: Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation, 2005, 79, 702-709. (Pubitemid 40463177)
43. Florescu, D. F., Islam, M. K., Mercer, D. F., et al.: Adenovirus infections in pediatric small bowel transplant recipients. Transplantation, 2010, 90, 198-204.
44. Khoo, S. H., Bailey, A. S., de Jong, J. C., et al.: Adenovirus infections in human immunodefi ciency virus-positive patients: clinical features and molecular epidemiology. J. Infect. Dis., 1995, 172, 629-637.
45. De Jong, J. C., Wermenbol, A. G., Verweij-Uijterwaal, M. W., et al.: Adenoviruses from human immunodefi ciency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J. Clin. Microbiol., 1999, 37, 3940-3945.
46. Kliewer, S., Garcia, J., Pearson, L., et al.: Multiple transcriptional regulatory domains in the human immunodefi ciency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity. J. Virol., 1989, 63, 4616-4625. (Pubitemid 19257836)
47. Hierholzer, J. C., Wigand, R., Anderson, L. J., et al.: Adenoviruses from patients with AIDS: a plethora of serotypes and a description of fi ve new serotypes of subgenus D (types 43-47). J. Infect. Dis., 1988, 158, 804-813.
48. Ongrádi, J., Csata, S., Farkas, J., et al.: Transfected lymphocyte extracts of patients with urological tumours: complement temperature-sensitive adenovirus mutants in vitro. Int. Urol. Neph-rol., 1994, 26, 361-373. (Pubitemid 24293988)
49. Kajon, A. E., Dickson, L. M., Fisher, B. T., et al.: Fatal disseminated adenovirus infection in a young adult with systemic lupus erythematosus. J. Clin. Virol., 2011, 50, 80-83.
50. Perl, A., Fernandez, D., Telarico, T., et al.: Endogenous retro-viral pathogenesis in lupus. Curr. Opin. Rheumatol., 2010, 22, 483-492.
51. Howard, D. S., Phillips, I. G., Reece, D. E., et al.: Adenovirus infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis., 1999, 29, 1494-1501. (Pubitemid 30022747)
52. Adeyemi, O. A., Yeldandi, A. V., Ison, M. G.: Fatal adenovirus pneumonia in a person with AIDS and Burkitt lymphoma: a case report and review of the literature. AIDS Read., 2008, 18, 196-198, 201-202, 206-207.
53. Echavarria, M., Sanchez, J. L., Kolavic-Gray, S. A., et al.: Rapid detection of adenovirus in throat swab specimens by PCR during respiratory disease outbreaks among military recruits. J. Clin. Microbiol., 2003, 41, 810-812. (Pubitemid 36184202)
54. Allard, A., Girones, R., Juto, P., et al.: Polymerase chain reaction for detection of adenoviruses in stool samples. J. Clin. Micro-biol., 1990, 28, 2659-2667.
55. Sester, M., Sester, U., Alarcon Salvador, S., et al.: Age-related decrease in adenovirus-specifi c T cell responses. J. Infect. Dis., 2002, 185, 1379-1387. (Pubitemid 34507958)
56. Neofytos, D., Ojha, A., Mookerjee, B., et al.: Treatment of adeno-virus disease in stem cell transplant recipients with cidofovir. Biol. Blood Marrow Transplant., 2007, 13, 74-81. (Pubitemid 46044089)
57. Muller, R., Ditzen, A., Hille, K., et al.: Detection of herpesvirus and adenovirus co-infections with diagnostic DNA-microar-rays. J. Virol. Methods, 2009, 155, 161-166.
58. Guérin-El Khourouj, V., Dalle, J. H., Pedron, B., et al.: Quantitative and qualitative CD4 T cell immune responses related to ad-enovirus DNAemia in hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant., 2011, 17, 476-485.
59. Hoffman, J. A., Shah, A. J., Ross, L. A., et al.: Adenoviral infections and a prospective trial of cidofovir in pediatric hemato-poietic stem cell transplantation. Biol. Blood Marrow Transplant., 2001, 7, 388-394. (Pubitemid 32799057)
60. Saquib, R., Melton, L. B., Chandrakantan, A., et al.: Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin. Transpl. Infect. Dis., 2010, 12, 77-83.
61. Waye, M. M. Y., Sing, C. W.: Anti-viral drugs for human adeno-viruses. Pharmaceuticals, 2010, 3, 3343-3354.
62. Tóth, K., Spencer, J. F., Dhar, D., et al.: Hexadecyloxypropyl- cido-fovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc. Natl. Acad. Sci. USA, 2008, 105, 7293-7297. (Pubitemid 351754471)
63. Paolino, K., Sande, J., Perez, E., et al.: Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001. J. Clin. Virol., 2011, 50, 167-170.
64. Florescu, D. F., Pergam, S. A., Neely, M. N., et al.: Safety and ef-fi cacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biol. Blood Marrow Transplant., 2012, 18, 731-738.
65. Morfi n, F., Dupuis-Girod, S., Mundweiler, S., et al.: In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir. Ther., 2005, 10, 225-229. (Pubitemid 41151028)
66. Arav-Boger, R., Echavarria, M., Forman, M., et al.: Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr. Infect. Dis. J., 2000, 19, 1097-1100.
67. Chakrabarti, S., Collingham, K. E., Fegan, C. D., et al.: Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant., 1999, 23, 1209-1211. (Pubitemid 29259681)
68. Bruno, B., Gooley, T., Hackman, R. C., et al.: Adenovirus infection in hematopoietic stem cell transplantation: effect of ganci-clovir and impact on survival. Biol. Blood Marrow Transplant., 2003, 9, 341-352. (Pubitemid 38351819)
69. Kurosaki, K., Miwa, N., Yoshida, Y., et al.: Therapeutic basis of vidarabine on adenovirus-induced haemorrhagic cystitis. Anti-vir. Chem. Chemother., 2004, 15, 281-285. (Pubitemid 39452247)
70. Kawakami, M., Ueda, S., Maeda, T., et al.: Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant., 1997, 20, 485-490. (Pubitemid 27434897)
71. Bordigoni, P., Carret, A. S., Venard, V., et al.: Treatment of ade-novirus infections in patients undergoing allogeneic hemato-poietic stem cell transplantation. Clin. Infect. Dis., 2001, 32, 1290-1297. (Pubitemid 32405900)
72. D'Cruz, O. J., Uckun, F. M.: Stampidine: a selective oculo-geni-tal microbicide. J. Antimicrob. Chemother., 2005, 56, 10-19.
73. Cawood, R., Chen, H. H., Carroll, F., et al.: Use of tissue-specifi c microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog., 2009, 5, e1000440.
74. Pirofski, L. A., Casadevall, A.: Use of licensed vaccines for active immunization of the immunocompromised host. Clin. Micro-biol. Rev., 1998, 11, 1-26. (Pubitemid 28046013)
75. Feuchtinger, T., Lang, P., Hamprecht, K., et al.: Isolation and expansion of human adenovirus-specifi c CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunothe-rapy. Exp. Hematol., 2004, 32, 282-289. (Pubitemid 38328534)